BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT04895709 updates: 1. completion date: 2028-07-07 → 2031-08-31 2. primary completion date: 2028-07-07 → 2031-08-31 3. enrollment: 949 → 1109 participants 4. allocation: NON_RANDOMIZED → RANDOMIZED
Clinical trial NCT04895709 updates: 1. completion date: 2028-07-07 → 2031-08-31 2. primary completion date: 2028-07-07 → 2031-08-31 3. enrollment: 949 → 1109 participants 4. allocation: NON_RANDOMIZED → RANDOMIZED
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical